TENELAR-M

bt_bb_section_bottom_section_coverage_image
https://www.larivinpharma.com/wp-content/uploads/2024/04/TENELAR-M.jpg

Composition

Active Ingredients:

  • Teneligliptin 20 mg
  • Metformin SR 500 mg

Description:
Tenelar-M combines Teneligliptin and Metformin in a single tablet, providing a dual mechanism for managing type 2 diabetes mellitus. This formulation offers the benefits of a DPP-4 inhibitor and prolonged-release Metformin to help achieve optimal blood glucose control.

Indications:
Tenelar-M is indicated for:

  • Management of type 2 diabetes mellitus in adults.
  • As an adjunct to diet and exercise to improve glycemic control.
  • Use in patients inadequately controlled with Metformin or Teneligliptin alone.

Mechanism of Action:

  • Teneligliptin: A DPP-4 inhibitor that increases incretin hormone levels, which enhances insulin secretion and lowers glucagon levels, thereby improving glucose control.
  • Metformin SR: A prolonged-release formulation that decreases hepatic glucose production and increases insulin sensitivity in peripheral tissues, facilitating better glucose uptake and utilization.

Dosage and Administration:

  • The recommended dose is one tablet of Tenelar-M daily, taken with or after the morning meal.
  • Dosage adjustments may be needed based on individual patient response and blood glucose levels.

Contraindications:

  • Hypersensitivity to Teneligliptin, Metformin, or any component of the tablet.
  • Severe renal impairment or significant liver dysfunction.
  • Type 1 diabetes mellitus or diabetic ketoacidosis.
  • Pregnancy and breastfeeding.

Warnings and Precautions:

  • Monitor renal function regularly due to the Metformin component.
  • Caution is advised in patients with a history of gastrointestinal issues or hypoglycemia.
  • Discontinue use and seek medical attention if symptoms of lactic acidosis (e.g., unusual muscle pain, difficulty breathing) or severe hypoglycemia occur.

Side Effects:
Common side effects may include:

  • Nausea
  • Diarrhea
  • Headache
  • Abdominal pain

Serious side effects, although rare, may include:

  • Lactic acidosis
  • Severe hypoglycemia
  • Pancreatitis

Drug Interactions:

  • May interact with other antidiabetic medications, particularly those affecting glucose metabolism.
  • Caution is advised with medications that have renal excretion or those affecting renal function.

Storage:

  • Store in a cool, dry place, away from direct sunlight.
  • Keep out of reach of children.

Packaging:

  • Available in blister packs of 10 tablets.

Disclaimer:
This information is provided for educational purposes only. For personalized medical advice and treatment options, consult a healthcare professional.

https://www.larivinpharma.com/wp-content/uploads/2020/06/large_blue_triangle_04.png
https://www.larivinpharma.com/wp-content/uploads/2024/04/TENELAR-M.jpg
https://www.larivinpharma.com/wp-content/uploads/2020/04/small_blue_triangle.png
https://www.larivinpharma.com/wp-content/uploads/2020/06/large_blue_triangle_01.png
https://www.larivinpharma.com/wp-content/uploads/2023/03/larivin-pharma-footer-icon-160x160.png
No.32, First Floor, Varadharaja Swamy Nagar, Sri Krishna Nagar, Maduravoyal, Chennai, Tamil Nadu 600095

© 2023 Larivin Pharma Private Limited. All rights reserved